Allmed Medical Financials
| 002950 Stock | 9.57 0.10 1.03% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 579.6 M | 374 M |
|
|
Allmed | Select Account or Indicator |
Understanding current and past Allmed Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Allmed Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Allmed Medical's assets may result in an increase in income on the income statement.
Please note, the presentation of Allmed Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Allmed Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Allmed Medical's management manipulating its earnings.
Allmed Medical Stock Summary
Allmed Medical competes with Industrial, China Construction, Agricultural Bank, Bank of China, and PetroChina. Allmed Medical is entity of China. It is traded as Stock on SHE exchange.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | China Stock View All |
| Exchange | Shenzhen Stock Exchange |
| ISIN | CNE100003JM5 |
| Business Address | Taurus Plaza, Block |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | cn.allmed-china.com |
| Phone | 86 75 5882 99300 |
You should never invest in Allmed Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Allmed Stock, because this is throwing your money away. Analyzing the key information contained in Allmed Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Allmed Medical Key Financial Ratios
Allmed Medical's financial ratios allow both analysts and investors to convert raw data from Allmed Medical's financial statements into concise, actionable information that can be used to evaluate the performance of Allmed Medical over time and compare it to other companies across industries.| Revenue | 2.76 B | ||||
| Gross Profit | 742.84 M | ||||
| EBITDA | 518.43 M | ||||
| Net Income | 110.4 M | ||||
| Total Asset | 5.08 B |
Allmed Medical Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 4.9B | 5.0B | 5.7B | 5.1B | 5.8B | 4.3B | |
| Retained Earnings | 1.7B | 1.6B | 1.7B | 1.7B | 2.0B | 1.2B | |
| Accounts Payable | 143.9M | 253.9M | 897.3M | 326.1M | 375.0M | 296.3M | |
| Cash | 1.3B | 678.5M | 522.2M | 397.0M | 456.6M | 544.4M | |
| Net Receivables | 238.5M | 589.0M | 483.2M | 376.4M | 432.9M | 380.3M | |
| Inventory | 707.3M | 846.6M | 877.3M | 707.2M | 813.3M | 711.3M | |
| Other Current Assets | 243.9M | 119.6M | 81.9M | 56.2M | 50.6M | 48.1M | |
| Total Liab | 1.9B | 2.3B | 2.6B | 1.9B | 2.2B | 1.8B | |
| Short Long Term Debt | 1.1B | 1.1B | 792.1M | 749.6M | 862.0M | 800.5M | |
| Total Current Assets | 2.8B | 2.2B | 2.4B | 1.8B | 2.0B | 2.0B | |
| Intangible Assets | 219.5M | 234.7M | 213.6M | 202.7M | 233.1M | 208.6M | |
| Other Current Liab | 161.7M | 144.0M | 16.1M | 7.8M | 7.0M | 6.6M | |
| Other Liab | 245.8M | 289.4M | 367.7M | 486.0M | 558.9M | 360.7M | |
| Net Tangible Assets | 1.1B | 1.9B | 2.7B | 2.5B | 2.9B | 2.0B | |
| Other Assets | 94.1M | 106.2M | 137.6M | 139.2M | 160.1M | 132.0M | |
| Long Term Debt | 100M | 127.6M | 111.4M | 146.3M | 131.7M | 120.5M | |
| Net Invested Capital | 4.1B | 3.9B | 4.0B | 4.1B | 4.7B | 3.6B | |
| Net Working Capital | 1.4B | 604.5M | 332.0M | 454.1M | 522.2M | 681.2M |
Allmed Medical Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Tax Provision | 178.2M | 73.5M | 80.3M | 64.8M | 74.5M | 84.1M | |
| Net Interest Income | (12.8M) | (19.1M) | (38.6M) | (31.3M) | (28.2M) | (29.6M) | |
| Interest Income | 6.5M | 4.2M | 3.1M | 1.9M | 2.1M | 2.5M | |
| Interest Expense | 17.7M | 17.2M | 35.5M | 31.9M | 36.6M | 24.1M | |
| Total Revenue | 3.8B | 2.9B | 4.2B | 2.8B | 3.2B | 2.9B | |
| Gross Profit | 1.6B | 881.5M | 1.4B | 768.6M | 883.9M | 994.9M | |
| Operating Income | 1.2B | 458.3M | 877.6M | 325.3M | 374.0M | 579.6M | |
| Ebit | 285.8M | 398.7M | 1.2B | 387.6M | 445.8M | 537.5M | |
| Research Development | 118.1M | 94.6M | 107.7M | 77.4M | 89.0M | 81.3M | |
| Cost Of Revenue | 2.2B | 2.0B | 2.8B | 2.0B | 2.3B | 1.9B | |
| Income Before Tax | 1.3B | 505.5M | 484.9M | 169.0M | 194.4M | 184.7M | |
| Net Income | 1.2B | 431.2M | 406.8M | 110.4M | 127.0M | 120.6M | |
| Ebitda | 552.9M | 1.5B | 669.9M | 713.6M | 820.6M | 779.2M | |
| Income Tax Expense | 50.1M | 70.0M | 178.2M | 73.5M | 84.6M | 92.6M | |
| Minority Interest | 12.4M | (745.6K) | 2.1M | 6.2M | 5.6M | 5.4M |
Allmed Medical Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Allmed Medical Products. It measures of how well Allmed is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Allmed Medical brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Allmed had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Allmed Medical has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | 18.5M | (143.4M) | (37.1M) | 71.1M | 81.8M | 85.8M | |
| Investments | (620.7M) | (83.5M) | (970.5M) | (215.5M) | (193.9M) | (203.6M) | |
| Change In Cash | 1.1B | (639.1M) | (159.8M) | (113.2M) | (101.9M) | (96.8M) | |
| Depreciation | 142.2M | 144.5M | 193.2M | 227.4M | 261.5M | 151.5M | |
| Dividends Paid | 266.5M | 577.2M | 163.9M | 65.2M | 58.7M | 55.8M | |
| Capital Expenditures | 243.3M | 290.7M | 398.0M | 286.5M | 329.5M | 316.8M | |
| Net Income | 1.2B | 431.2M | 406.8M | 110.4M | 127.0M | 120.6M | |
| End Period Cash Flow | 1.3B | 662.8M | 502.9M | 389.7M | 448.2M | 520.0M | |
| Net Borrowings | 435.4M | (494.1M) | 623.2M | 44.4M | 40.0M | 38.0M | |
| Free Cash Flow | 1.2B | 84.2M | 751.7M | 137.0M | 157.6M | 269.4M | |
| Other Non Cash Items | (5.6M) | (15.5M) | 177.7M | 42.9M | 49.4M | 43.1M | |
| Change To Netincome | 34.3M | 25.9M | (87.9M) | (51.6M) | (46.5M) | (44.1M) |
Allmed Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Allmed Medical's current stock value. Our valuation model uses many indicators to compare Allmed Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Allmed Medical competition to find correlations between indicators driving Allmed Medical's intrinsic value. More Info.Allmed Medical Products is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.49 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Allmed Medical Products is roughly 2.05 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Allmed Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Allmed Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Allmed Medical Products Systematic Risk
Allmed Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Allmed Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was sixty with a total number of output elements of one. The Beta measures systematic risk based on how returns on Allmed Medical Products correlated with the market. If Beta is less than 0 Allmed Medical generally moves in the opposite direction as compared to the market. If Allmed Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Allmed Medical Products is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Allmed Medical is generally in the same direction as the market. If Beta > 1 Allmed Medical moves generally in the same direction as, but more than the movement of the benchmark.
Allmed Medical Products Total Assets Over Time
Allmed Medical Thematic Clasifications
Allmed Medical Products is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Allmed Medical February 3, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Allmed Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Allmed Medical Products. We use our internally-developed statistical techniques to arrive at the intrinsic value of Allmed Medical Products based on widely used predictive technical indicators. In general, we focus on analyzing Allmed Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Allmed Medical's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.32 | |||
| Information Ratio | 0.0507 | |||
| Maximum Drawdown | 15.07 | |||
| Value At Risk | (3.62) | |||
| Potential Upside | 4.52 |
Complementary Tools for Allmed Stock analysis
When running Allmed Medical's price analysis, check to measure Allmed Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allmed Medical is operating at the current time. Most of Allmed Medical's value examination focuses on studying past and present price action to predict the probability of Allmed Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Allmed Medical's price. Additionally, you may evaluate how the addition of Allmed Medical to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |